Showing posts with label CORONAVIRUS VACCINE. Show all posts
Showing posts with label CORONAVIRUS VACCINE. Show all posts

April 16, 2021

'It's Not A Never Thing' — White, Rural Southerners Hesitant To Get COVID Vaccine

 NPR

Hartsville, Tenn., resident Rick Bradley, 62, received his first COVID-19 vaccine

Blake Farmer/WPLN

There are more than enough shots to go around in communities such as Hartsville, Tenn., the seat of Trousdale County, a quiet town tucked in the wooded hills northeast of Nashville.

It's a county that is nearly 90% white and where Donald Trump won nearly 75% of the votes in 2020. There was no special planning to reach underserved communities here, other than the inmates at the state prison, which experienced one of the nation's largest correctional facility outbreaks of COVID-19.

But now Tennessee, like much of the nation, is finding that rural, white residents need a little more coaxing to roll up their sleeves for the shot. This week, the state published results from a statewide survey, and a focus group of unvaccinated residents. More than 45% of white, rural conservatives said they were unwilling even to consider taking the vaccine.

"There's nothing inherently unique about living in a rural area that makes people balk at getting vaccinated. It's just that rural areas have a larger share of people in the most vaccine-resistant groups: Republicans and white evangelical Christians," says Drew Altman, president and CEO of the Kaiser Family Foundation.

The foundation's latest survey data find that more rural residents have been fully vaccinated than urban dwellers. But this is likely because there haven't been the same long waits in rural areas to get the vaccine. And now the initial demand has tapered to a drip. Currently, the number of rural residents (21%) saying they'll never get the vaccine is twice the number (10%) in urban areas.

On a recent weekend in Hartsville, the local health department had trouble filling up even half the spots for a COVID-19 vaccination event at the high school. Down the street at the Piggly Wiggly grocery store, Cris Weske, 43, stopped in to buy a can of dipping tobacco. He says he isn't even tempted to get the COVID-19 vaccine, no matter how widely available it is.

"Somebody like me that's healthy, with a survival rate of 99%, I don't need it," he says. "I don't want to put that toxin — I'm kind of anti-vax, period."

Weske, who is wearing a "We the People" T-shirt, says the U.S. Constitution protects his choice to opt out of the massive nationwide vaccination effort.

Residents line up for COVID-19 vaccinations inside a Walgreens in Hartsville. The local pharmacy across the street also offers vaccinations, along with the public health department around the corner.

Blake Farmer/WPLN

Public health officials in Tennessee expected to face some reluctance when the COVID-19 vaccine finally arrived. But they were surprised to realize that the most stubborn group might be white, largely conservative residents in rural Tennessee.

National polling by NPR, PBS NewsHour and Marist finds that rural, white Republicans — particularly supporters of Trump's — are among the least likely to get a vaccine. The issue is evident in state-by-state vaccination rates, with Alabama, Georgia, Mississippi and Tennessee trailing the rest of the country. The White House has begun launching new initiatives targeting so-called red states, such as setting up partnerships with NASCAR, professional sports and even country music.

"We voted for Trump, but Trump's got nothing to do with us not taking the vaccine," says Hartsville's Cindi Kelton, 67, as she loads dog food and milk into her minivan outside the Piggly Wiggly. "We were planning on taking it — until our doctor passed away."

More scared of the vaccine than the virus

Her physician, Raymond Fuller of Gallatin, Tenn., died of COVID-19 in late January. It's unclear whether he had been vaccinated. Either way, Kelton worried the vaccine could have played a role despite how safe it has been shown to be in rigorous clinical trials.

Kelton has chronic obstructive pulmonary disease and emphysema — lung diseases that put her at high risk of complications with COVID-19 — but maintains she's still more scared of the vaccine than the virus.

In many rural communities, scant attention has been paid to batting down rumors or answering vaccine questions. Public health officials in Tennessee and other Southern states have been far more focused on building trust with Black and immigrant groups concentrated in urban areas. And even their outreach in rural communities has targeted those traditionally underserved groups.

Cindi Kelton, 67, of Hartsville says she was planning to take the vaccine until her physician died of COVID-19 in January.

Blake Farmer/WPLN

But some leaders of rural communities are the ones actively sowing doubts. They include state legislators pushing anti-vaccine legislation and even a few pastors piping up on Sunday mornings. Greg Locke is an outspoken white preacher in Mount Juliet, Tenn., who peppers his sermons with mocking questions.

"People say, 'Well, what are you going to do when they make the vaccine mandatory?' " he asks an audience gathered without masks in late March. "I'm going to tell them to take a hike, like I've been telling them to take a hike. That's what I'm going to do."

Southern states, where vaccination rates are the lowest in the country, have frequently turned to ministers, seeing them as key allies who are trusted at the local level. But it's mostly Black churches, from Mississippi to Georgia, that have agreed to hold informational town halls or organize and host vaccine events.

In recent days, some key white evangelical leaders have stepped forward to advocate more loudly for vaccinations. Among them is J.D. Greearpresident of the Southern Baptist Convention. But Greear pastors a church in Durham, N.C. — hardly a conservative stronghold. And the responses to Greear on social media were impassioned and even irate — exposing how divided many conservative churchgoers are.

The white Baptist pastors in Hartsville, when contacted for this story, declined to weigh in, saying they were leaving the decision entirely up to members of their congregations.

"Wait and see"

Pastor Omaràn Lee, a hospital chaplain in Nashville, has been working with Black churches in Tennessee to promote vaccination. He says the concerns in Black congregations in his city aren't that different from what he hears from rural, white communities.

" 'We don't trust the government, and we don't trust Joe Biden' is what they say, right?" he says.

But Lee notes that, six months ago, Black communities were saying the same thing when Trump was in office. "Anytime you have a marginalized person, you have people who [feel] left out, they're going to be skeptical."

Skepticism about the vaccine, Lee says, can be overcome if there's an intentional effort to reach people where they are.

But in small towns such as Hartsville, there hasn't been much attention on the issue. People are less likely to hear the message from church leaders, and other communication can be more limited. There's not much in the way of local media providing information about how to sign up and where to go.

"I don't even have a computer. I'm old school," says Brenda Kelley, a 74-year-old widow who says she didn't even know she was eligible to get the vaccine yet, much less that tons of shots are available. The vaccination event at a nearby high school was advertised mostly on Facebook.

"Kinda scared to get it in a way, and in a way I want it," Kelley added. "And my children, neither of them want it. So I don't know."

Plus, Kelley has her own questions she'd like answered first — such as whether her diabetes, while elevating her risk of developing serious COVID-19, might also cause problems with the vaccine. Health officials say the vaccine is safe for people like her, but she wants to hear it from her doctor.

"It's not a never thing," she concludes. Just a "wait and see."

April 7, 2021

Biden Says All Adults Will Be Vaccine Eligible By April 19

 NPR

People wait in their vehicles to get vaccinated last week at a drive-through site at Hard Rock Stadium in Miami Gardens, Fla. President Biden announced an April 19 deadline for all states to open eligibility to individuals ages 18 and up.

Chandan Khanna/AFP via Getty Images

President Biden announced Tuesday that he is moving up the deadline for states to open up COVID-19 vaccinations to all U.S. residents 18 and older by about two weeks. Less than a month after directing states to expand eligibility to all adults by May 1, Biden changed that deadline to April 19.

"No more confusing rules, no more confusing restrictions," Biden said.

The president made his announcement after visiting a vaccination site at Virginia Theological Seminary in Alexandria, an Episcopal institution founded in 1823. His visit was intended to highlight the participation of religious organizations in the vaccination effort.

Most states have either made vaccines available to all residents 16 and older or announced plans to do so by mid-April. The White House did not say how it intends to get the handful of remaining states to move up their timelines.

Officials announced at the end of March that nearly half of states were set to expand eligibility to all adults by April 15, and that 46 states and Washington, D.C., would do so by May 1. In the weeks since, the remaining four states — New YorkWyomingSouth Carolina and Arkansas — have all opened vaccines to the general public.

Biden also announced that the U.S. administered 150 million doses in his first 75 days in office, a pace that puts the administration on track to surpassing his previously stated goal of reaching 200 million doses in his first 100 days.

The country is averaging 3.1 million shots per day over a seven-day period, White House officials said Monday, and reached a new milestone over the weekend with an unprecedented 4 million vaccinations recorded in one day. Nearly 1 in 4 adults are fully vaccinated, officials added.

According to NPR's vaccine tracker, 18.8% of the U.S. population is fully vaccinated, and 32.4% has had at least one dose. The states with the highest percentage of their populations vaccinated include New Mexico, South Dakota, Alaska, Rhode Island and Maine.

February 28, 2021

FDA Authorizes Johnson & Johnson's One-Shot COVID-19 Vaccine

 NPR

A health care worker holds a vial of the Johnson & Johnson COVID-19 vaccine at Klerksdorp Hospital in Klerksdorp, South Africa, on Feb. 18.

PHILL MAGAKOE/AFP via Getty Images

A third COVID-19 vaccine is on the way, and this one requires only one shot for immunization.

The Food and Drug Administration authorized Johnson & Johnson's vaccine for emergency use Saturday, a day after a panel of advisers to the agency voted unanimously (22-0) in its favor.

"The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States," said a statement by Acting FDA Commissioner Janet Woodcock.

The Johnson & Johnson vaccine was tested in an international study of about 40,000 people, half of whom got the vaccine and half of whom got a placebo. The study found the company's vaccine to be 66% effective overall in preventing moderate to severe COVID-19 disease. For disease judged severe or critical, the effectiveness was 85%. The study was conducted in the U.S., South America and South Africa.

The main study included in the company's application found that 28 days or more after immunization, the Johnson & Johnson vaccine prevented hospitalizations and deaths related to COVID-19.

The overall efficacy figures are lower than Pfizer's 95% in preventing COVID-19 disease and 94% for Moderna. But direct comparisons are challenging because of differences in the clinical trials and emergence of new strains of the coronavirus.

The Johnson & Johnson vaccine "is very effective ... at preventing severe disease after a single dose and it induces the kind of response, so-called cellular immune response, that looks like it's going to have fairly long-lived memory, which is all good," Dr. Paul Offit, a member of the FDA's advisory panel, told NPR's Scott Simon on Weekend Edition Saturday. "This certainly provides protection against what you care about, which is hospitalization, ICU admission and death. It's virtually 100% effective at doing that." Offit is also director of the Vaccine Education Center at the Children's Hospital of Philadelphia.

As the pandemic has drawn on, the coronavirus has mutated. Variants first seen in South Africa and Brazil, where the Johnson & Johnson vaccine was tested, developed mutations that help them evade the immune response prompted by previous infections with the original form of the virus and vaccines designed against it. Some of the variants, including one first identified in the U.K, are more contagious.

In the South African portion of the Johnson & Johnson study, the company's vaccine was 64% effective in preventing moderate to severe disease. In the Latin American region, the vaccine was 61% effective.

The FDA's analysis of the safety data found that "a favorable safety profile with no specific safety concerns" for the vaccine. As part of the vaccine study more than 6,000 people were asked about their reactions, and the most common side effects they reported were pain at the injection site (49%), headache (39%), fatigue (38%) and muscle pain (33%).

While COVID-19 cases in the U.S. have fallen dramatically since their January peak, Centers for Disease Control and Prevention Director Rochelle Walensky warned during a White House briefing Friday that the 7-day average of confirmed cases had ticked up in the past three days and represents a "very concerning shift in trajectory." The 7-day average for cases was 67,207 on Friday, up from 65,426 on Tuesday.

"Things are tenuous. Now is not the time to relax restrictions," Walensky said. "Although we have been experiencing large declines in cases and hospital admissions over the past six weeks, these declines follow the highest peak we have experienced in the pandemic."

She also warned that the continued spread of coronavirus variants in the U.S. threatens to reverse gains in containing the pandemic.

Besides mitigation measures like mask-wearing and physical distancing, vaccination is an important public health tool. More than 48 million people, or almost 15% of the U.S. population, have received at least one dose of a COVID-19 vaccine, according to CDC figures out Saturday. More than 23 million, or 7% of the population, have received two doses of the either the Moderna or Pfizer vaccines.

Johnson & Johnson's addition to the coronavirus fight will be limited at first. The company has said it would have 4 million doses ready to go when the FDA green lights its vaccine. By the end of March, the company expects to be able to supply 20 million doses and to deliver 100 million doses by the end of June.